Unconventional screening approaches for antibiotic discovery
- PMID: 26100135
- DOI: 10.1111/nyas.12803
Unconventional screening approaches for antibiotic discovery
Abstract
The dramatic rise in microbial drug resistance in recent years has led to ongoing searches for novel drugs to add to the armory against infectious disease. Nevertheless, a paucity of new antibacterial drugs in discovery and development pipelines using traditional approaches has prompted a variety of unconventional and disruptive strategies for antibacterial drug discovery. Herein, we review recent nontraditional approaches that have been piloted for early drug discovery efforts. These unique methodologies open new avenues for finding the next generation of antimicrobials.
Keywords: antibiotic discovery; high-throughput screening; unconventional methodologies.
© 2015 New York Academy of Sciences.
Similar articles
-
Postgenomic strategies in antibacterial drug discovery.Future Microbiol. 2010 Oct;5(10):1553-79. doi: 10.2217/fmb.10.119. Future Microbiol. 2010. PMID: 21073314 Review.
-
Alternative natural sources for a new generation of antibacterial agents.Int J Antimicrob Agents. 2013 Sep;42(3):195-201. doi: 10.1016/j.ijantimicag.2013.05.004. Epub 2013 Jun 21. Int J Antimicrob Agents. 2013. PMID: 23796893 Review.
-
Bacterial histidine kinases as novel antibacterial drug targets.ACS Chem Biol. 2015 Jan 16;10(1):213-24. doi: 10.1021/cb5007135. Epub 2014 Dec 26. ACS Chem Biol. 2015. PMID: 25436989 Review.
-
(Dis)similar Analogues of Riboswitch Metabolites as Antibacterial Lead Compounds.J Med Chem. 2015 Apr 23;58(8):3275-86. doi: 10.1021/jm500868e. Epub 2015 Feb 3. J Med Chem. 2015. PMID: 25603286 Review.
-
Keeping it simple: lessons from the golden era of antibiotic discovery.FEMS Microbiol Lett. 2016 Apr;363(8):fnw084. doi: 10.1093/femsle/fnw084. Epub 2016 Mar 31. FEMS Microbiol Lett. 2016. PMID: 27036144 Review.
Cited by
-
Drug repurposing for antimicrobial discovery.Nat Microbiol. 2019 Apr;4(4):565-577. doi: 10.1038/s41564-019-0357-1. Epub 2019 Mar 4. Nat Microbiol. 2019. PMID: 30833727 Review.
-
Chemogenomic model identifies synergistic drug combinations robust to the pathogen microenvironment.PLoS Comput Biol. 2018 Dec 31;14(12):e1006677. doi: 10.1371/journal.pcbi.1006677. eCollection 2018 Dec. PLoS Comput Biol. 2018. PMID: 30596642 Free PMC article.
-
Auxotrophy-based High Throughput Screening assay for the identification of Bacillus subtilis stringent response inhibitors.Sci Rep. 2016 Oct 24;6:35824. doi: 10.1038/srep35824. Sci Rep. 2016. PMID: 27775002 Free PMC article.
-
Identification of Efflux Substrates Using a Riboswitch-Based Reporter in Pseudomonas aeruginosa.mSphere. 2023 Apr 20;8(2):e0006923. doi: 10.1128/msphere.00069-23. Epub 2023 Mar 22. mSphere. 2023. PMID: 36946743 Free PMC article.
-
Unrealized targets in the discovery of antibiotics for Gram-negative bacterial infections.Nat Rev Drug Discov. 2023 Dec;22(12):957-975. doi: 10.1038/s41573-023-00791-6. Epub 2023 Oct 13. Nat Rev Drug Discov. 2023. PMID: 37833553 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical